These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31623310)

  • 1. Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline).
    Fam SY; Chee CF; Yong CY; Ho KL; Mariatulqabtiah AR; Lau HY; Tan WS
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-Defined SiO2@P(EtOx-stat-EI) Core-Shell Hybrid Nanoparticles via Sol-Gel Processes.
    Eckardt O; Pietsch C; Zumann O; von der Lühe M; Brauer DS; Schacher FH
    Macromol Rapid Commun; 2016 Feb; 37(4):337-42. PubMed ID: 26676077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.
    Biabanikhankahdani R; Alitheen NBM; Ho KL; Tan WS
    Sci Rep; 2016 Nov; 6():37891. PubMed ID: 27883070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dual Bioconjugated Virus-Like Nanoparticle as a Drug Delivery System and Comparison with a pH-Responsive Delivery System.
    Biabanikhankahdani R; Ho KL; Alitheen NB; Tan WS
    Nanomaterials (Basel); 2018 Apr; 8(4):. PubMed ID: 29652827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple Add-and-Display Method for Immobilisation of Cancer Drug on His-tagged Virus-like Nanoparticles for Controlled Drug Delivery.
    Biabanikhankahdani R; Bayat S; Ho KL; Alitheen NBM; Tan WS
    Sci Rep; 2017 Jul; 7(1):5303. PubMed ID: 28706267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. μPET imaging of the pharmacokinetic behavior of medium and high molar mass (89)Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol).
    Wyffels L; Verbrugghen T; Monnery BD; Glassner M; Stroobants S; Hoogenboom R; Staelens S
    J Control Release; 2016 Aug; 235():63-71. PubMed ID: 27235979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel PEtOx-Based Nanogel Targeting Prostate Cancer Cells for Drug Delivery.
    Gülyüz S; Sessevmez M; Ukuser G; Khalily MP; Tiryaki S; Sipahioglu T; Birgül K; Ömeroğlu İ; Özçubukçu S; Telci D; Küçükgüzel ŞG; Durmuş M; Cevher E; Yılmaz Ö
    Macromol Biosci; 2024 Mar; 24(3):e2300324. PubMed ID: 37827519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled ciprofloxacin-loaded poly(2-ethyl-2-oxazoline) nanoparticles from dry powder inhaler formulation for the potential treatment of lower respiratory tract infections.
    Sabuj MZR; Dargaville TR; Nissen L; Islam N
    PLoS One; 2021; 16(12):e0261720. PubMed ID: 34941946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
    Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
    Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(2-methyl-2-oxazoline) conjugates with doxorubicin: From synthesis of high drug loading water-soluble constructs to in vitro anti-cancer properties.
    Sedlacek O; Van Driessche A; Uvyn A; De Geest BG; Hoogenboom R
    J Control Release; 2020 Oct; 326():53-62. PubMed ID: 32565042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.
    Wingfield PT; Stahl SJ; Williams RW; Steven AC
    Biochemistry; 1995 Apr; 34(15):4919-32. PubMed ID: 7711014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of the hepatitis B core antigen particle truncated at residue 154.
    Liu S; He J; Li K; Dai A; Cai C; Zhang J
    Sci China Life Sci; 2011 Feb; 54(2):171-4. PubMed ID: 21104034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(2-ethyl-2-oxazoline)-IR780 conjugate nanoparticles for breast cancer phototherapy.
    Alves CG; Lima-Sousa R; Melo BL; Ferreira P; Moreira AF; Correia IJ; Melo-Diogo D
    Nanomedicine (Lond); 2022 Nov; 17(27):2057-2072. PubMed ID: 36803049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the Surface of Nanoparticles: Impact of Poly(2-ethyl-2-oxazoline) on Protein Adsorption in Serum and Cellular Uptake.
    Koshkina O; Westmeier D; Lang T; Bantz C; Hahlbrock A; Würth C; Resch-Genger U; Braun U; Thiermann R; Weise C; Eravci M; Mohr B; Schlaad H; Stauber RH; Docter D; Bertin A; Maskos M
    Macromol Biosci; 2016 Sep; 16(9):1287-300. PubMed ID: 27281039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions.
    Sabuj MZR; Rashid MA; Dargaville TR; Islam N
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.